PGN-EDODM1 — Topline data
Nov 2026
The FREEDOM2 study has completed enrollment of the 10 mg/kg dose cohort with seven of eight patients having completed dosing, and we expect to report data from this cohort in November, 2026.Source filing
PEPG biotech catalysts & pipeline
PEPGEN INC · Data as of 2026-09-08
Upcoming catalysts
PGN-EDODM1 — Interim data
Jan 2027
Update from the OLE study is expected by early January.Source filing